FlowPed
Remote Patient Data Monitoring Platform for Moderate-severe Incontinent Sufferers
Company Overview
Snapshot
Founded in January 2024 by David Grey, Lee Sahar, and Noam Hadas, FlowPed operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing innovative solutions for remote patient data monitoring.
Business overview
FlowPed is a Health Tech & Life Sciences company developing a novel nursing and diagnostic platform for individuals suffering from moderate to severe bladder control difficulties. The company's core product, Dry-One, is a self-drying interactive pad designed for extended use, alongside a remote patient data monitoring platform. This platform provides continuous transparency of a patient's condition, enabling controlled treatment and symptom reduction, and utilizes AI-enabled analysis to identify dehydration and urinary infections. FlowPed targets the digital healthcare market, serving patients, providers, and the aging population in North America and Europe.
Log in to access full profile ›Company Intelligence Q&A
- What is FlowPed's primary focus?
- FlowPed focuses on developing a remote patient data monitoring platform and a novel nursing and diagnostic platform to improve care for individuals with moderate to severe bladder control difficulties.
- When was FlowPed founded?
- FlowPed was founded in January 2024.
- Who are the founders of FlowPed?
- FlowPed was founded by David Grey, Lee Sahar, and Noam Hadas.
- What is FlowPed's main product?
- FlowPed developed Dry-One, a self-drying interactive pad that requires changing only once every 24 hours, and a remote patient data monitoring platform.
- Which markets does FlowPed target?
- FlowPed targets the North American and European markets, focusing on the aging population and healthcare providers.